Last reviewed · How we verify
NCT07043686
Cerebrolysin in Early Stroke Rehabilitation - Tertiary Study
NA trial testing Cerebrolysin treatment in Ischemic Stroke, Acute in 30 participants. Currently enrolling.
15 July 2027
Quick facts
| Lead sponsor | University Medical Centre Ljubljana |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 30 |
| Start date | 13 June 2025 |
| Primary completion | 15 July 2027 |
| Estimated completion | 15 October 2027 |
| Sites | 1 location across Slovenia |
Drugs / interventions tested
- Cerebrolysin treatment — full drug profile →
- Standard treatment (including neurorehabilitation) of acute ischemic stroke
Conditions studied
- Ischemic Stroke, Acute — all drugs for Ischemic Stroke, Acute →
- Rehabilitation Outcome — all drugs for Rehabilitation Outcome →
- Cerebrolysin — all drugs for Cerebrolysin →
Sponsor
University Medical Centre Ljubljana
Who can join
18 and older, any sex, with Ischemic Stroke, Acute or Rehabilitation Outcome. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The study evaluates the effect and safety of Cerebrolysin administered during early rehabilitation in patients with moderate neurological impairment after acute ischemic stroke, conducted at the Department of Vascular Neurology and Intensive Neurological Therapy, UMC Ljubljana.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07043686
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Ischemic Stroke, Acute
Currently open trials in the same condition.
- NCT06639360 — Effects of Transcranial Magnetic Stimulation After Endovascular Treatment for Acute Ischemic Stroke · NA · recruiting
- NCT06920303 — Accuracy of Transcranial Colour Coded Duplex in Comparing With CT Angiography · recruiting
- NCT06712004 — A Dose-Response Controlled Trial of Bevifibatide for Acute Ischemic Stroke · Phase 2 · recruiting
- NCT06726941 — Effect of Exercise Gene Expression and Histone Modifications in Patients With Hemiplegia · NA · recruiting
- NCT06094478 — Hospital Implementation of a Stroke Protocol for Emergency Evaluation and Disposition · NA · recruiting
Other University Medical Centre Ljubljana trials
Trials by the same sponsor.
- NCT07466472 — Image-Guided Central Catheter Insertion With Concurrent Assessment of Vascular Wall Integrity · not yet recruiting
- NCT07446244 — Catheter Ablation of Advanced Forms of Atrial Fibrillation · NA · enrolling by invitation
- NCT07109076 — Effect of Immediate Skin-to-Skin Contact on Neonatal Heart Rate Variability After Cesarean Secton · NA · recruiting
- NCT07354880 — Effect of Tirzepatide on Cardiovascular and Metabolic Parameters in Obese Adult Patients With Congenital Heart Disease · Phase 4 · not yet recruiting
- NCT07496736 — Post-exposure Influenza Prophylaxis in a Hospital Setting · Phase 3 · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07043686 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University Medical Centre Ljubljana
- Last refreshed: 9 July 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07043686.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing